Formulations of bendamustine | Patent Publication Number 20190350904

US 20190350904 A1

Patent NumberUS 11103483 B2

Application Number16509920

Filled DateJul 12, 2019

Priority DateJan 28, 2010

Publication DateNov 21, 2019

Original AssigneeEagle Pharmaceuticals Inc.

Current AssigneeJpmorgan Chase Bank

Inventor/ApplicantsPhilip Christopher Buxton
Nagesh R. Palepu

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.